ponatinib,blinatumomab
amgen,takeda,incyte,otsuka,astellas
['ponatinib', 'cml', 'leukemia', 'blinatumomab', 'leusm']
congress #asco22 | reports on a phase ii study of ponatinib + blinatumomab in pts with either nd ph+all, r/r ph+all or cml. (n=55) 96% nd all pts achieved cr/cri and of the r/r ph+all pts 92% achieved cr/cri and 83% in cml pts #leusm #leukemia 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm